Julie Howard’s SEC Form 4 filings reveal a pattern dominated by compensation-driven equity accumulation rather than discretionary market activity. Across 49 reported transactions in two companies, she recorded zero open-market purchases and only a single open-market sale, totaling a modest $1,424.74. That sale occurred on June 22, 2026, in Sleep Number Corporation (SNBR), and represents the entirety of her sell-side activity. The overwhelming majority of her reported value—roughly $1.23 million in acquired shares—came from “A” codes, which denote grants or awards, not purchases. These are compensation events, not conviction buys.
The bulk of that acquisition value is concentrated in ManpowerGroup (MAN), where Howard received a series of annual equity grants on January 1 of both 2025 and 2026. The 2026 tranche alone included two large awards valued at $179,985.42 and $179,981.72, supplemented by roughly a dozen smaller grants ranging from $165.92 to $4,479.84. The 2025 grants followed a similar structure, with two principal awards near $180,000 and $171,597.21, plus several smaller allocations. In total, the MAN grants account for nearly all of her reported acquisition value, while the SNBR activity is limited to a single award on May 21, 2026, and the subsequent small sale.
The transaction pattern is consistent with a director or executive receiving scheduled equity compensation and making one minor liquidity-driven sale. There is no evidence of a directional bet: no open-market buys, no large discretionary sells, and no option exercises or tax-withholding events in the recent window. The data suggests Howard’s insider activity is largely mechanical, tied to annual compensation cycles rather than market timing. Her only sale, at roughly $1,400, is immaterial relative to the $1.23 million in granted equity, indicating no meaningful reduction in her stake.
AI-assisted summary